Cmed has announced the opening of its second US office in Durham, North Carolina. The company said the new office is established to meet the needs of the customers and the growing business.
David Connelly, CEO of Cmed, said: “We are very excited about establishing a second US base and our new offices in Durham, close to Research Triangle Park (RTP), are the perfect location for Cmed. RTP continues to be a model for innovation, education, and economic development and our new offices will allow us to draw on the tremendously skilled workforce in the Raleigh-Durham-Chapel Hill area, and to get close to our customers to provide even better service.
“Our priority will be to build our Biostatistics team, but we will also continue to grow our Clinical and Data Management capabilities in line with our customers’ needs. The goal is to establish a true ‘state of the art’, integrated clinical operations group providing clinical, data management and biostatistics services around our sophisticated Timaeus technology. This will enable Cmed to offer genuinely cost effective services even in such operationally challenging areas as Adaptive Trial Design and the complexities of oncology.”
Cmed established its first US foothold in 2001 with offices in New Providence, New Jersey, before moving to Murray Hill, New Jersey.